155 related articles for article (PubMed ID: 31302615)
21. Type 1 diabetes in a melanoma patient treated with ipilimumab after nivolumab.
Omodaka T; Kiniwa Y; Sato Y; Suwa M; Sato M; Yamaguchi T; Sato A; Miyake T; Okuyama R
J Dermatol; 2018 Oct; 45(10):e289-e290. PubMed ID: 29667767
[No Abstract] [Full Text] [Related]
22. Pseudo-Progression of Melanoma Treated with Nivolumab/Ipilimumab: A Case Report.
Cuevas Velazquez AM; Ng WL; Calderón Martínez EJ; Yeruva SLH
Am J Case Rep; 2023 Aug; 24():e940954. PubMed ID: 37545116
[TBL] [Abstract][Full Text] [Related]
23. [Malignant mucous primary sinonasal melanoma. A clinic case].
Balderrama Caballero DH; de García Hombre AM; Llorente Suárez R; Martín Salvago MD; Rodríguez Adrados F
An Otorrinolaringol Ibero Am; 2007; 34(3):273-80. PubMed ID: 17725171
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and toxicity of ipilimumab used after nivolumab in patients with melanoma.
Sato M; Uhara H; Koga H; Okuyama R
J Dermatol; 2018 Oct; 45(10):e287-e289. PubMed ID: 29655228
[No Abstract] [Full Text] [Related]
25. [The epidemiology and clinical characteristics of malignant melanoma localized in nasal cavity and paranasal sinuses--analysis of 6 cases].
Ziółkowska M; Bień S; Klimas A; Zyłka S
Otolaryngol Pol; 2008; 62(4):500-3. PubMed ID: 18837235
[TBL] [Abstract][Full Text] [Related]
26. Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study.
Long GV; Atkinson V; Lo S; Sandhu S; Guminski AD; Brown MP; Wilmott JS; Edwards J; Gonzalez M; Scolyer RA; Menzies AM; McArthur GA
Lancet Oncol; 2018 May; 19(5):672-681. PubMed ID: 29602646
[TBL] [Abstract][Full Text] [Related]
27. Site-specific response patterns, pseudoprogression, and acquired resistance in patients with melanoma treated with ipilimumab combined with anti-PD-1 therapy.
Pires da Silva I; Lo S; Quek C; Gonzalez M; Carlino MS; Long GV; Menzies AM
Cancer; 2020 Jan; 126(1):86-97. PubMed ID: 31584722
[TBL] [Abstract][Full Text] [Related]
28. Single-center retrospective series of fourteen patients with mucosal melanoma of the nasal cavity and paranasal sinuses.
Letievant JC; Poupart M; Ambrun A; Colin C; Pignat JC
Eur Ann Otorhinolaryngol Head Neck Dis; 2016 Dec; 133(6):387-391. PubMed ID: 27502822
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Two Dosing Regimens for Nivolumab in Combination With Ipilimumab in Patients With Advanced Melanoma: Results From the Phase IIIb/IV CheckMate 511 Trial.
Lebbé C; Meyer N; Mortier L; Marquez-Rodas I; Robert C; Rutkowski P; Menzies AM; Eigentler T; Ascierto PA; Smylie M; Schadendorf D; Ajaz M; Svane IM; Gonzalez R; Rollin L; Lord-Bessen J; Saci A; Grigoryeva E; Pigozzo J
J Clin Oncol; 2019 Apr; 37(11):867-875. PubMed ID: 30811280
[TBL] [Abstract][Full Text] [Related]
30. Oncologic outcomes, prognostic factor analysis and therapeutic algorithm evaluation of head and neck mucosal melanomas in France.
Moya-Plana A; Aupérin A; Obongo R; Baglin A; Ferrand FR; Baujat B; Saroul N; Casiraghi O; Vergez S; Herman P; Janot F; Thariat J; Vérillaud B; de Gabory L;
Eur J Cancer; 2019 Dec; 123():1-10. PubMed ID: 31670075
[TBL] [Abstract][Full Text] [Related]
31. [Primary malignant melanoma of the nasal cavity].
Mayol Belda MJ; Ballester Moll F; Sánchez Ramos MA; Cantavella Ventura J; Vera Luna JA; Beladíez Romero P
Acta Otorrinolaringol Esp; 1989; 40(1):57-9. PubMed ID: 2629930
[TBL] [Abstract][Full Text] [Related]
32. Primary malignant melanoma of the nasal cavity: report of two cases and review of the literature.
Sidoni A; Ottaviani F; Maurizi M
Histol Histopathol; 1987 Jul; 2(3):299-306. PubMed ID: 2980733
[TBL] [Abstract][Full Text] [Related]
33. Aural metastasis from a nasal malignant melanoma: case report with literature review.
Khan I; Mohamad S; Shakeel M; Jaramillo MJ
J Laryngol Otol; 2011 Dec; 125(12):1290-3. PubMed ID: 21854692
[TBL] [Abstract][Full Text] [Related]
34. Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy: Increased rate and mimicker of metastasis.
Chorti E; Kanaki T; Zimmer L; Hadaschik E; Ugurel S; Gratsias E; Roesch A; Bonella F; Wessendorf TE; Wälscher J; Theegarten D; Schadendorf D; Livingstone E
Eur J Cancer; 2020 May; 131():18-26. PubMed ID: 32248071
[TBL] [Abstract][Full Text] [Related]
35. Combination Nivolumab/Ipilimumab Immunotherapy For Melanoma With Subsequent Unexpected Cardiac Arrest: A Case Report and Review of Literature.
Khoury ZH; Hausner PF; Idzik-Starr CL; Frykenberg MRA; Brooks JK; Dyalram D; Basile JR; Younis RH
J Immunother; 2019 Oct; 42(8):313-317. PubMed ID: 31206394
[TBL] [Abstract][Full Text] [Related]
36. Malignant melanoma of nasal cavity: case report and review of the literature.
Malaguarnera M; Vinci M; Pistone G
Cancer Biother Radiopharm; 2002 Feb; 17(1):29-34. PubMed ID: 11915171
[No Abstract] [Full Text] [Related]
37. Investigation of clinical factors associated with longer overall survival in advanced melanoma patients treated with sequential ipilimumab.
Muto Y; Kitano S; Tsutsumida A; Namikawa K; Takahashi A; Nakamura Y; Yamanaka T; Yamamoto N; Yamazaki N
J Dermatol; 2019 Jun; 46(6):498-506. PubMed ID: 30945333
[TBL] [Abstract][Full Text] [Related]
38. Current concepts in advanced sinonasal mucosal melanoma: a single institution experience.
Meerwein CM; Hüllner M; Braun R; Soyka MB; Morand GB; Holzmann D
Eur Arch Otorhinolaryngol; 2019 Aug; 276(8):2259-2265. PubMed ID: 31098872
[TBL] [Abstract][Full Text] [Related]
39. Primary amelanotic melanoma of the nasal cavity: a case report.
Gupta S; Pant MC; Husain N; Sundar S; Khan H
Ear Nose Throat J; 2014 Jan; 93(1):E12-4. PubMed ID: 24452896
[TBL] [Abstract][Full Text] [Related]
40. Malignant melanoma of nasal cavity and paranasal sinuses: report of 24 patients and literature review.
Clifton N; Harrison L; Bradley PJ; Jones NS
J Laryngol Otol; 2011 May; 125(5):479-85. PubMed ID: 21255478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
